SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Indications -- Hepatitis
An SI Board Since March 2001
Posts SubjectMarks Bans
312 28 0
Emcee:  tuck Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
62finance.messages.yahoo.com Re: Winner or Losers by: leftbeforelayoff 03/14/04 scaram(o)uche-3/15/2004
61CDC reviewing Hepatitis C license agreement made with Chiron, which has been gratuck-2/17/2004
60Here's another brand new pipeline summary in similar vein, with some differetuck-2/13/2004
59Micrologix acquires clinical-stage hepatitis C drug candidate VANCOUVER, Ferusset-2/3/2004
58Coley Pharmaceutical Group Initiates Phase I Clinical Trials of Actilon(TM) for nigel bates-1/13/2004
57Metabasis Therapeutics and Merck Announce a Collaboration to Develop New Treatmenigel bates-1/13/2004
56Nice summary: Message 19637185keokalani'nui-12/30/2003
55[Inhibition of host protein geranylgeranylation as therapeutic strategy for HCV tuck-12/10/2003
54[BILN - 2061 for Hep C: further color from Nature Reviews] >>Nature Revietuck-11/18/2003
53[HCV: small molecule NS3 protease inhibitors -- Boehringer Ingelheim -- BILN 206tuck-11/3/2003
52Vertex Pharmaceuticals Reports Six-Month Results from Phase II Clinical Study ofrusset-10/18/2003
51>>Published online before print September 22, 2003 Proc. Natl. Acad. Sci. tuck-9/22/2003
50The internet is the only way doctors can be brought up to speed with the leadingrusset-8/24/2003
49American Journal of Pathology. 2003;163:1167-1175 Morphine Enhances Hepatitis Cscaram(o)uche-8/24/2003
48Immtech Compounds Show Promise Against Flavivirus (Hepatitis C and BVDV) And Aniscaram(o)uche-8/11/2003
47RNA interference (RNAi) — the process in which double-stranded RNA (dsRNA) bindsrusset-7/28/2003
46[HepC. GenMab Inlicense. E2 envelope glycoprotein.] Genmab Expands Pipeline wikeokalani'nui-7/14/2003
45Interesting parts bolded as usual Mr. Phelps (gggggggg) Researchers identify clrusset-7/3/2003
44[Memory CD8+ T-Cells] >>J Exp Med. 2003 Jun 16;197(12):1645-55. Memorytuck-6/19/2003
43Roche / Maxygen / Next-Generation Interferon Alpha and Beta Message 18965663 ..nigel bates-5/22/2003
42[HCB - RNAi -- short hairpins] >>Nat Biotechnol 2003 May 12; [epub ahead tuck-5/19/2003
41[HCV -- Viral particle immunization] >>Published online before print May tuck-5/14/2003
40[siRNA] >>EMBO Rep 2003 Jun;4(6):1-7 Inhibition of intracellular hepattuck-5/13/2003
39Hepatitis C Drug Market to Grow from $2.5 Billion in 2002 to More Than $9 Billiokeokalani'nui-5/13/2003
38[siRNA vs. HCV update] [in vivo] Nat Med 2003 Mar;9(3):347-51 RNA interferenctuck-5/8/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News